Table 5.
BPA levels in human tissues and fluids during pregnancy and lactation.
Reference | Detection method | LOD (ng/mL) | Sample size | End point(s) | Study population | BPA level [ng/mL (ppb), mean ± SE] |
---|---|---|---|---|---|---|
Ikezuki et al. 2002 | ELISA | 0.3 | 32 | Early amniotic fluid (15–18 weeks) | Pregnant Japanese women | 8.3 ± 1.573 |
38 | Late amniotic fluid (at full term, before delivery) | Pregnant Japanese women undergoing cesarian section | 1.1 ± 0.162 | |||
36 | Follicular fluid | Japanese women undergoing IVF procedures | 2.4 ± 0.133 | |||
Schönfelder et al. 2002 | Derivatization-GC-MS | 0.01 | 37 | Placenta | German women at delivery | 11.2 ± 1.512 ng/g |
Todaka and Mori 2002 | GC-MS | NR | NR | Umbilical cord tissue at birth | Samples collected in Japan | Mean, 4.4 ± 1.5 ng/g; range, 0.11–15.2 ng/g |
Yamada et al. 2002 | ELISA | 0.5 | 200 | Normal fetal amniotic fluid (14–18 weeks) | Pregnant Japanese women | Median, 0.26; range, ND–5.62 |
48 | Abnormal fetal karyotype fetal amniotic fluid (14–18 weeks) | Pregnant Japanese women | Median, 0 | |||
Otaka et al. 2003 | SPE-GC-MS | 0.09 | 3 | Breast milk | Japanese women | Range, ND–0.70 ng/g |
Sun et al. 2004 | DIB-Cl derivatization-HPLC | 0.11 | 23 | Breast milk | Japanese women | 0.61 ± 0.042 |
Engel et al. 2006 | HPLC-electrochemical detection | 0.5 | 21 | Residual amniotic fluid from amniocentesis, < 20 weeks’ gestation | American women > 35 years of age | Mean, 0.55 (10% > 0.5 ng/mL) |
Ye et al. 2006 | Online SPE-HPLC-MS/MS | 0.28 | 20 | Breast milk | American women | Unconjugated BPA: mean, 1.3; 60% detection Total BPA: mean, 1.9; 90% detection |
Kuruto-Niwa et al. 2007 | ELISA | 0.3 | 101 | Human colostrum | Japanese women 3 days after delivery | 3.41 ± 0.013 |
Ye et al. 2008a | Online SPE-HPLC-MS/MS | 0.3 | 4 | Breast milk | American women | Unconjugated BPA: mean, 0.80 Total BPA: mean, 1.02 |
Kaddar et al. 2009 | RIA | 0.08 | 17 | Follicular fluid | French women undergoing IVF procedures | Range, ND–1.0; 39% detection |
Abbreviations: DIB-Cl, 4-(4,5-diphenyl-1H-imidazol-2-yl)benzoyl chloride; ND, not detected; SPE, solid-phase extraction.